Boehringer Ingelheim Vetmedica, Inc.
GPTKB entity
Statements (49)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
gptkb:Boehringer_Ingelheim_Animal_Health
gptkb:Vetoquinol Merial |
gptkbp:awards |
Industry awards
Sustainability awards Innovation awards |
gptkbp:communityInvolvement |
Local charities
Educational initiatives Veterinary outreach programs |
gptkbp:conference |
Veterinary conferences
Research conferences Animal health symposiums |
gptkbp:employees |
Over 1,000
|
gptkbp:established |
2000
|
gptkbp:financials |
Market share
Revenue in billions Investment in R&D Annual growth rate |
gptkbp:focus |
Veterinary medicine
|
gptkbp:foundedBy |
gptkb:Boehringer_Ingelheim
|
gptkbp:futurePlans |
New product development
Expansion in emerging markets Increased investment in technology |
gptkbp:globalPresence |
gptkb:Asia
gptkb:Latin_America gptkb:North_America Africa Europe |
gptkbp:headquarters |
gptkb:St._Joseph,_Missouri,_USA
|
https://www.w3.org/2000/01/rdf-schema#label |
Boehringer Ingelheim Vetmedica, Inc.
|
gptkbp:industry |
Pharmaceuticals
|
gptkbp:market |
Global
|
gptkbp:parentCompany |
gptkb:Boehringer_Ingelheim
|
gptkbp:partnerships |
Research institutions
Veterinary schools Animal health organizations |
gptkbp:products |
Antibiotics
Vaccines Parasiticides |
gptkbp:researchFocus |
Diagnostics
Therapeutics Vaccination technology |
gptkbp:specializesIn |
Animal health
|
gptkbp:subsidiary |
gptkb:Boehringer_Ingelheim
|
gptkbp:sustainabilityInitiatives |
Community engagement
Animal welfare Environmental responsibility |
gptkbp:website |
www.boehringer-ingelheim.com
|